I agree, If By-Health want to launch as soon as the health claim is approved, and I think this would be a good idea (strike while the iron is hot so to speak), then we need the stock on hand or even better with By-Health.
My guess (or hope) is that we pay for a chunk of the new stock ourselves and the remainder on consignment. |
I'm not sure that we have enough stock to see us through till Blue-Hat is approved.
Total value of stock ( including FF+ ) at the end of Sept was 152k.
We issued shares to the value of 564k in December, but that included settling up our royalty payment. I'm guessing a bit, but I'm assuming the royalty payment was >=200k, so the shares issued might have added 350k to our inventory.
So total inventory in Dec 2024 was likely in the order of 500k.
In H1, our cost of goods was 512k, giving a revenue of 785k. So, if sales for H2 are the same, then we'll likely be short of inventory next month.
However, from what we've been told about orders being processed, it seems likely that our revenues for H2 will be less than H1, which gives more wriggle room.
End of the day, needing more inventory is a good thing though. |
Let’s hope so ,that would be best for shareholders if they care about that . |
IMO if a raise is needed to buy stock it will come straight after the bi-health announcement of approval (fingers crossed that is) |
Rp I suppose when funding has been sorted .,and hopefully we will know the demand by the size of the raise ! Stated in the last results higher demand will require a much larger funding amount . |
winner31 I am sure that details on the likely scale of orders expected will not be forthcoming.The fact that they have got away with the same cut and paste for so long whilst being paid as though we were actually a highly profitable company is risible.
Provexis is no more than the classic Aim director lifestyle/jam tomorrow company.Anyone who has not fully grasped this by now is beyond help. |
Well that’s January gone of the “early months”, you would think the assessment of customer need over the next 24 months must be complete by now , funding has to be found pretty soon if the new production run needs to be completed by March or April .
Wonder if we’ll be informed of the demand (I doubt it) .
My gut feeling is all will be kept very quiet,and so the share price will languish for another 8 months .. |
Yes I would not be surprised if there is a HNWI placing to fund the purchase of stock.That is a strong possibility but By-Health launching is a strong probability and when that happens I won't want to buy at the likely share price then hence my decision to buy now.
What this really means is a discounted placing accompanied by a share price crash and me feeling miffed at missing a better price!!
Let's face it Provexis is the share that never fails to disappoint! |
I hope it works out for you RP. Until the next round of funding is put into place it's pretty much a lottery at the moment.
One of my worries about the recent share options being set well below the share price is, if we raise cash by issuing lots of shares, then new and investing investors may well be looking for a discount similar to what the board have given themselves.
Gixer - let's hope so, that would probably be the best option for ordinary shareholders. |
I think we will get news on stock before we hear anything on China. How this will be funded is the big question.
Maybe IF will pull another rabbit out the hat and persuade the third party he is in negotiations with to hold the stock on consignment. Then the question would be.... Who is the third party? |
Well done rp ,think you will be ok this time ,as you say news from China could push the share price over the 1p mark and hopefully it will stay there . |
Well I had some money in my SIPP (part proceeds of a takeover on another stock) so for better or worse I added another tranche last week.My reasoning was even though a fund raise cannot be ruled out in the near term,news from China could come at any time.Added at around or just below my average.
Probably see share price fall this week on news of a placing if my track record on timing is anything to go by. |
Thanks Winner - that's good to know |
Bk just read rules on de-listing and he would need a 75% votes to do that ,also a de-list would null and void options so I don’t think IF would want that not until they vest anyway . |
Winner
Simple answer is, I don't know.
Less simple answer is, I thought it was a simple majority ( so 50% of all shares, plus one ) ? Though, to make life easier for themselves, the person / company making the offer might well make 75% the minimum on a take it or leave it basis... basically so they don't end up with lots of dissenting shareholders to deal with once they've taken it private.
fwiw - I don't think it's likely Lucas would try to take us private. On his own, or with family, I doubt he has deep enough pockets, though he could be the conduit for some private equity funding. Having said that, I'd say there's more chance of him fronting a takeover than DSM.
RedPrince
Just so there's no confusion. The approx 0.37p I posted was the average for the shares Ford can currently exercise and not the ones from this week's RNS ... which, under normal circumstances don't vest until 2027. |
I know in the US stock option strike price cannot be below the fair market value of the stock at the time of the award - by law. Surprised this is not the case in UK also
siggy |
Correct me if I’m wrong ,I believe Lucas would need 75% of the vote to take us private ! Assuming the board would vote for it and obviously Lucas and Dsm would vote for , think it’s something like 30% ish of the shares , not sure how he would achieve the remainder, but who knows with a new huge fundraiser coming up . Imo |
What people need to bear in mind is that Lucas's interests may not necessarily be aligned with those of the oridinary pi.
The level of denial about the lowly strike price by some of the usual suspects on the red channel defies logic.
I think it is a bit of Stockholm syndrome combined with ego driven denial that we have been slowly kippered and diluted in part by the excessive greed of the bod.
To be clear IF has been a steady pair of hands but he is more than economical with the facts and that imo serves to suit his puprose and not that of the pi.
The latest news simply underlines what i have been saying for years now. |
Agree I haven’t been here for so many years for a few pence per share , completely against going private , that to me would be an absolute betrayal of ordinary shareholders! |
winner - the fact that the new options are at an average of 0.37 is far from encouraging.Ofc we do not know the performance conditions attached to them.
The RNS imo should have been less ambiguous in terms of detailing the performance conditionality and also clear as to what change of control means.
Fwiw i will be resolutely opposed to any t/o approach before we can ascertain the worth of the Chinese deal and doubly opposed to any attempt by Lucas to take us private or any attempt to delist pxs from AIM. |
Anyway seems to be a bit greedy ,, unless of course they raise a huge amount of funding at .5p then .35 p wouldn’t look so bad !
With continued talk over the last 5 years in every rns that a SAMR approval and Dsm gut health launch would expect Significant and substantial multiples of probably £1.5 m income , seems strange that some people talk about a buyout price of 2p ,valuing the company at £47m when revenue could easily surpass that .! Everyone has their own agenda I suppose! |
Winner
Your statement is wrong. Yes, his last set of options were set at .83p, but he has 35 million options which are exercisable today at an average of ~0.37p |
RP his optIons we’re set at .83p last time 52million .perhaps he felt he is paying to much for those and wanted to average down ,if only we could all do that without paying for them .!
Perhaps those awarded to sales and scientific teams are in lieu of salary , just a thought. |
IF already had options - this is just the latest tranche.Shocklingly low strike price. |
With no NEDS what else do you expect.
siggy |
Register to chat with like-minded investors on our interactive forums.
Hot Features
Premium
